Condition
Heart Failure Due to Coronary Artery Disease
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownDelayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyNCT07572032 · 2026-05-20
RECRUITINGEfficacy of Lipoic Acid on Chronic Ischemic Heart Failure PatientsNCT07725484 · 2026-11-01
NOT_YET_RECRUITINGOptimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart FailureNCT02775578 · 2016-04-01
UNKNOWNCommon interventions
Leading sponsors
Trial status mix
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1
Phase mix
NA1
PHASE31
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.